This review examines pharmacological agents for sleep disorders, highlighting efficacy and emerging therapies.
Sleep disorders, are involved insomnia, restless legs syndrome (RLS), narcolepsy, and obstructive sleep apnea (OSA), affect millions worldwide, significantly impacting health and quality of life. Pharmacological treatment remains a cornerstone in the management of these conditions, with diverse agents targeting different pathways. This review provides a comprehensive examination of the pharmacological agents used in treating sleep disorders, covering their mechanisms of action, efficacy, safety, and clinical application. Additionally, it highlights emerging therapies and future next way in the field.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: